Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Journal of Parkinson'S Disease|December 13, 2021
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II)Mathilde Boussac, Christophe Arbus, Helene Klinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 20, 2026
One-Year Substantia Nigra R 2 * Changes across Parkinson's Disease StagesCalvin Coussediere, Bruno Pereira, David Devos, et al.
Clinical Parkinsonism & Related Disorders|February 20, 2026
Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale)Christian Matta, Camille Comet, Corentin Gaillard, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
The Lancet. Neurology|June 5, 2012
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trialCaroline Moreau, Arnaud Delval, Luc Defebvre, et al.
Brain : a Journal of Neurology|March 26, 2015
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's diseaseCaroline Moreau, Sayah Meguig, Jean-Christophe Corvol, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 17, 2018
Suggestive association between OPRM1 and impulse control disorders in Parkinson's diseaseFlorence Cormier-Dequaire, Samir Bekadar, Mathieu Anheim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 27, 2025
Type and position of repeat interruptions as determinants of disease severity and expansion size in Friedreich ataxiaMehdi Benkirane, Cecilia Marelli, Ariane Choumert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2025
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)Olivier Rascol, Fabienne Ory-Magne, Wassilios G Meissner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 5, 2024
Amantadine use in the French prospective NS-Park cohortMargherita Fabbri, Vanessa Rousseau, Jean-Christophe Corvol, et al.
Pageof 8